Search alternatives:
post » most (Expand Search)
Showing 1,701 - 1,720 results of 1,945 for search 'post repeatability', query time: 0.10s Refine Results
  1. 1701
  2. 1702

    Intradetrusor OnabotulinumtoxinA outcomes for overactive bladder in older adults by Rachel Stading, Natalia Hernandez, Julian Pacheco, Lia Miceli, Danielle D. Antosh, Julie N. Stewart, Ricardo Gonzalez, Yahir Santiago-Lastra, Rose Khavari

    Published 2024-12-01
    “…In a subgroup analysis of octogenerians (n = 50/210), 73% showed improvement in urgency and 68% had less incontinence post-injection. Discussion:: OnabotulinomtoxinA was well tolerated in patients older than 70 with improvement in overactive bladder symptoms and reduction in requirement of drug therapy.…”
    Get full text
    Article
  3. 1703

    Enhancing intraoral radiographic technique: introducing “Nallan's Lines” by Nallan CSK Chaitanya, Vivek Padmanabhan, Md Sofiqul Islam, Nada Tawfig Hashim, Riham Mohammed, Neeharika Satyajyothi Allam, Jouma Jalal Omar, Ahmed Zakaria, Shaga Pranathi, Mamindla Apoorva

    Published 2024-12-01
    “…By adhering to this geometric framework dental practitioners can minimize geometric distortions and thereby repeated radiographic exposures of patients.…”
    Get full text
    Article
  4. 1704

    Influence of high-definition transcranial direct current stimulation to the parietal cortex on postural control: a single-blind randomized crossover study by Fan Yang, Fan Yang, Yang Liu, Yang Liu, Xianglin Lv, Yaqi He, Jinpeng Gao, Pei Zhang, Qing Li, Zhongmei Peng, Jinghua Qian, Jinghua Qian

    Published 2025-05-01
    “…Bonferroni’s post hoc tests were used in case of significant ANOVA results.ResultsThe composite latency increased significantly after right (p = 0.025) and bilateral (p = 0.004) stimulation under eyes open condition. …”
    Get full text
    Article
  5. 1705

    Necrotizing pancreatitis complicated by retroperitoneal emphysema: two case reports by Kohei Chida, Keinosuke Ishido, Yoshiyuki Sakamoto, Norihisa Kimura, Hajime Morohashi, Takuya Miura, Taiichi Wakiya, Hiroshi Yokoyama, Hayato Nagase, Daichi Ichinohe, Akiko Suto, Daisuke Kuwata, Aika Ichisawa, Akie Nakamura, Daiki Kasai, Kenichi Hakamada

    Published 2022-09-01
    “…Case presentation Case 1: A 76-year-old man was referred to our hospital after being diagnosed with acute pancreatitis. At post-admission, his abdominal symptoms worsened, and a repeat CT scan revealed increased retroperitoneal gas. …”
    Get full text
    Article
  6. 1706
  7. 1707
  8. 1708

    Targeted protein editing technique in living mammalian cells by peptide-fused PNGase by Min Wu, Guijie Bai, Ziyi Zhang, Haixia Xiao, Wenliang Sun, Chaoguang Tian

    Published 2024-11-01
    “…Various precise gene editing techniques at the DNA/RNA level, driven by clustered regularly interspaced short palindrome repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) technology, have gained significant prominence. …”
    Get full text
    Article
  9. 1709

    Effect of a workplace-based learning program on clerkship students’ behaviors and attitudes toward evidence-based medicine practice by Hajime Kasai, Go Saito, Kenichiro Takeda, Hiroshi Tajima, Chiaki Kawame, Nami Hayama, Kiyoshi Shikino, Ikuo Shimizu, Kazuyo Yamauchi, Mayumi Asahina, Takuji Suzuki, Shoichi Ito

    Published 2024-12-01
    “…However, as its effects may not last more than six months, it may need to be repeated across departments throughout CC to change behavior in EBM practice.…”
    Get full text
    Article
  10. 1710

    Cardiac T1 mapping in non-ST-segment elevation myocardial infarction: temporal changes in myocardial fibrosis by Luis Paiva, Luis Paiva, Maria João Ferreira, Maria João Ferreira, Maria João Ferreira, Sónia Afonso, Sónia Afonso, Paulo Donato, Paulo Donato, Lino Gonçalves, Lino Gonçalves

    Published 2025-05-01
    “…These assessments were performed at baseline and repeated 6-10 months after MI.ResultsAt the 4-year post-MI follow-up, 27 patients survived [age 65 (58,74) years; 77% male], and LV mass, volume, and contractility remained unchanged between the baseline and follow-up measurements. …”
    Get full text
    Article
  11. 1711
  12. 1712
  13. 1713

    Are Perceived Effort Scales (OMNI-RES) Appropriate for Defining and Controlling Strength Training Intensity? by José Luis Maté-Muñoz, Luis Maicas-Pérez, Iñigo Aparicio-García, Juan Hernández-Lougedo, Luis De Sousa-De Sousa, Mónica Hontoria-Galán, Francisco Hermosilla-Perona, Manuel Barba-Ruiz, Pablo García-Fernández, Juan Ramón Heredia-Elvar

    Published 2025-02-01
    “…These sessions were repeated one week later. Results: significant differences were found between the four bench press protocols regarding the number of repetitions and the percentage of velocity loss per set (<i>p</i> < 0.001). …”
    Get full text
    Article
  14. 1714

    Effects on impulsivity and delay discounting of intermittent theta burst stimulation add-on to dialectical behavioral therapy in borderline personality disorder: a randomized, sham... by Milenko Kujovic, Christian Bahr, Mathias Riesbeck, Daniel Benz, Martina Deiß, Zsofia Margittai, Sebastian Henges, Dirk Reinermann, Christian Plewnia, Eva Meisenzahl

    Published 2025-01-01
    “…No significant differences were found between iTBS and sham, although post hoc tests revealed significant changes in impulsivity in the iTBS group (meandiff = -4.7, p = .001, Cohen’s d = 0.68) but not in the sham group (meandiff = -2.1, p = .077, d = 0.31). …”
    Get full text
    Article
  15. 1715
  16. 1716

    Does creatine cause hair loss? A 12-week randomized controlled trial by Mohammadyasin Lak, Scott C. Forbes, Damoon Ashtary-Larky, Sahar Dadkhahfar, Reza Mahmoud Robati, Farshid Nezakati, Makan Khajevandi, Sara Naseri, Arvin Gerafiani, Neda Haghighat, Jose Antonio, Grant M. Tinsley

    Published 2025-09-01
    “…While total testosterone increased (∆ = post value minus pre value: creatine = ∆124   ±   149 ng/dL; placebo = ∆216   ±   203 ng/dL) and free testosterone decreased (creatine = ∆-9.0   ±   8.7 pg/mL; placebo = ∆-9   ±   6.4 pg/mL) over time, these effects were independent of supplementation. …”
    Get full text
    Article
  17. 1717

    Results of a phase I/IIa trial of SV-BR-1-GM inoculation with low-dose cyclophosphamide and interferon alpha (Bria-IMT) in metastatic breast cancer by Charles L. Wiseman, Jarrod P. Holmes, Carmen Calfa, Shaker R. Dakhil, Saveri Bhattacharya, George E. Peoples, Markus D. Lacher, Miguel Lopez-Lago, Alex Kharazi, Giuseppe Del Priore, Mingjin Chang, Daniel L. Adams, William V. Williams

    Published 2024-12-01
    “…This Phase I/IIa open-label, single-arm clinical trial addressing advanced, refractory, metastatic breast cancer was conducted at six medical centers in the United States. We repeated inoculations with irradiated SV-BR-1-GM, a breast cancer cell line with antigen-presenting activity engineered to release granulocyte-macrophage colony-stimulating factor (GM-CSF), with pre-dose low-dose cyclophosphamide and post-dose local interferon alpha. …”
    Get full text
    Article
  18. 1718

    Dietary fibre to reduce colon cancer risk in Alaska Native people: the Alaska FIRST randomised clinical trial protocol by Jeremy K Nicholson, Jia V Li, James Kinross, Kathryn R Koller, Annette Wilson, Daniel P Normolle, Flora R Lee, Christie A Flanagan, Zoe T Merculieff, Priya Iyer, Daniela L Lammers, Timothy K Thomas

    Published 2021-08-01
    “…Following an 8-week stabilisation period to re-establish normal gut microbiota post colonoscopy, study personnel randomise participants to either a high fibre supplement (resistant starch, n=30) or placebo (digestible starch, n=30) condition, repeating stool sample collection. …”
    Get full text
    Article
  19. 1719

    Characterizing the recurrence of atrial arrhythmia following macro-reentrant atrial tachycardia ablation in adult patients with repaired tetralogy of Fallot by Bret L. Pinsker, MD, Anthony L. Lin, MD, John D. Serfas, MD, Zebulon Z. Spector, MD, Jonathan P. Piccini, MD, FHRS, Michael J. Campbell, MD, Richard A. Krasuski, MD

    Published 2025-08-01
    “…RA size and the presence of other atrial arrhythmia at ablation may predict recurrence. Extended courses of post-ablation anti-coagulation may prove beneficial in this population.…”
    Get full text
    Article
  20. 1720

    Health-related quality of life with bemarituzumab plus mFOLFOX6 in patients with FGFR2b-overexpressing, advanced gastric or gastroesophageal junction cancer by Z.A. Wainberg, P.C. Enzinger, S. Qin, K. Yamaguchi, J. Wang, X. Zhou, A. Gnanasakthy, K. Taylor, A. Yusuf, I. Majer, A. Jamotte, Y.-K. Kang

    Published 2024-12-01
    “…Analyses were exploratory post hoc. Results: PRO scale scores at baseline and compliance rates across PRO assessments over time were similar between the bemarituzumab and placebo arms. …”
    Get full text
    Article